Laxmi Organic (NSE: LXCHEM) rebuts pollution allegations at Lote plant, affirms full regulatory compliance
Laxmi Organic denies pollution comparisons at its Lote facility, affirming full compliance. Find out what this means for investors and industry observers.
Vikran Engineering (NSE: VIKRAN) wins 45.75 MW solar project under PM-KUSUM-C in Madhya Pradesh
Vikran Engineering wins 45.75 MW solar order in Madhya Pradesh under PM-KUSUM-C. Find out how this signals a bigger bet on feeder solarisation and rural energy.
Hanshow bets on academic firepower to scale ambient IoT in global retail networks
Hanshow and the University of Cambridge team up to develop intelligent hybrid wireless systems for scalable ambient IoT. Find out how this could reshape retail tech.
Tired of tourist traps in Japan? Tabelog’s new app could change the game
Tabelog now lets travelers book real Japanese restaurants in English, Chinese, and Korean. Find out how Kakaku.com is reshaping tourism through food.
Telcoin launches eUSD under U.S. bank charter, marking first regulated blockchain stablecoin
Find out how Telcoin’s eUSD is reshaping digital banking with the first U.S. regulated stablecoin. Discover the model behind blockchain-native banking.
Glioblastoma trial for MT027 moves forward as T-MAXIMUM debuts allogeneic cell therapy in CNS
T-MAXIMUM wins FDA clearance for MT027 in glioblastoma. Read how its non-viral, off-the-shelf CAR-T may reshape solid tumor cell therapy development.
Will Pictor’s targeted proteomics platform gain traction after CDC’s hepatitis B shift?
Pictor’s ViraScreen-Core test aligns with new CDC hepatitis B guidance. Find out how this multiplex assay could reshape antibody testing in clinical labs.
Hardy Diagnostics to distribute NEMIS Technologies’ N-Light test for on-site food pathogen detection
Hardy Diagnostics brings NEMIS Technologies’ rapid pathogen test to U.S. food manufacturers. Explore what this move means for QA teams, compliance, and competitors.
Rubraca beats docetaxel in TRITON3: FDA clears early-line prostate cancer use for Tolmar
Tolmar’s Rubraca gains FDA approval for BRCA-mutated prostate cancer before chemotherapy. Explore the trial results and what it means for treatment strategy.
Silvercorp Metals (TSX: SVM) releases $522m NPV PEA for Condor gold project in Ecuador
Silvercorp’s Condor PEA outlines a $522M NPV and 29% IRR. Find out how this Ecuador gold project could reshape its growth strategy. Read more.